Literature DB >> 29071466

Cardiovascular autonomic effects of vagus nerve stimulation.

Iñigo Garamendi-Ruiz1, Juan Carlos Gómez-Esteban2,3.   

Abstract

The vagus nerve is responsible for the parasympathetic innervation of the major thoracic and abdominal organs. It also carries sensory afferent fibres from these viscera and reaches different brain structures. These connections have proven useful in the treatment of different diseases. Afferent stimulation of the left vagus nerve is used to treat epilepsy and major depression, and stimulation of the right vagus nerve is being tried for the treatment of heart failure. The device used for the therapy delivers intermittent stimuli. It is indicated worldwide for the treatment of drug-resistant epilepsy in patients who are not appropriate candidates for respective surgery. It has also received approval for the treatment of major depression, obesity and episodic cluster headache by the Food and Drug Administration. Randomised controlled trials and prospective studies have confirmed the efficacy and safety of this therapy in epilepsy. Nevertheless, sporadic cases of ventricular asystole have been reported. To evaluate the effect of vagus nerve stimulation therapy on the autonomic nervous system, different studies that assess heart function and blood pressure changes have been conducted, although the methods employed were not homogeneous. These studies have found subtle or no significant changes in heart rate variability and blood pressure in epileptic patients. Moreover, this therapy may reduce the risk of one of the most lethal conditions in epilepsy-sudden unexpected death.

Entities:  

Keywords:  Autonomic system; Epilepsy; Heart failure; Vagus nerve stimulation

Year:  2017        PMID: 29071466     DOI: 10.1007/s10286-017-0477-8

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  83 in total

1.  The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus.

Authors:  Annelies Grimonprez; Robrecht Raedt; Jeanelle Portelli; Ine Dauwe; Lars Emil Larsen; Charlotte Bouckaert; Jean Delbeke; Evelien Carrette; Alfred Meurs; Veerle De Herdt; Paul Boon; Kristl Vonck
Journal:  J Psychiatr Res       Date:  2015-05-27       Impact factor: 4.791

2.  Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.

Authors:  Gaetano M De Ferrari; Harry J G M Crijns; Martin Borggrefe; Goran Milasinovic; Jan Smid; Markus Zabel; Antonello Gavazzi; Antonio Sanzo; Robert Dennert; Juergen Kuschyk; Srdjan Raspopovic; Helmut Klein; Karl Swedberg; Peter J Schwartz
Journal:  Eur Heart J       Date:  2010-10-28       Impact factor: 29.983

3.  Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy.

Authors:  Iñigo Garamendi; Marian Acera; Marta Agundez; Lara Galbarriatu; Ainhoa Marinas; Iñigo Pomposo; Elena Valle; Jose-Alberto Palma; Juan C Gomez-Esteban
Journal:  Seizure       Date:  2016-12-02       Impact factor: 3.184

4.  Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death.

Authors:  J F Annegers; S P Coan; W A Hauser; J Leestma
Journal:  Epilepsia       Date:  2000-05       Impact factor: 5.864

5.  Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.

Authors:  A John Rush; Harold A Sackeim; Lauren B Marangell; Mark S George; Stephen K Brannan; Sonia M Davis; Phil Lavori; Robert Howland; Mitchel A Kling; Barry Rittberg; Linda Carpenter; Philip Ninan; Francisco Moreno; Thomas Schwartz; Charles Conway; Michael Burke; John J Barry
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

6.  Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.

Authors:  Hermann Stefan; Gernot Kreiselmeyer; Frank Kerling; Katrin Kurzbuch; Christophe Rauch; Marcel Heers; Burkhard S Kasper; Thilo Hammen; Martina Rzonsa; Elisabeth Pauli; Jens Ellrich; Wolfgang Graf; Rüdiger Hopfengärtner
Journal:  Epilepsia       Date:  2012-05-03       Impact factor: 5.864

7.  Vagus nerve stimulation for refractory epilepsy: a transatlantic experience.

Authors:  Kristl Vonck; Vijay Thadani; Karen Gilbert; Stefanie Dedeurwaerdere; Liesbeth De Groote; Veerle De Herdt; Lut Goossens; Fleur Gossiaux; Erik Achten; Evert Thiery; Guy Vingerhoets; Dirk Van Roost; Jacques Caemaert; Jacques De Reuck; David Roberts; Peter Williamson; Paul Boon
Journal:  J Clin Neurophysiol       Date:  2004 Jul-Aug       Impact factor: 2.177

8.  Vagus nerve stimulation therapy for treatment-resistant epilepsy: a 15-year experience at a single institution.

Authors:  L Galbarriatu; I Pomposo; J Aurrecoechea; A Marinas; M Agúndez; J C Gómez; M A Acera; M J Martínez; E Valle; I Maestro; B Mateos; A Cabrera; J Fernández; F Iturri; I Garamendi
Journal:  Clin Neurol Neurosurg       Date:  2015-07-02       Impact factor: 1.876

Review 9.  Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity.

Authors:  Flavio Giordano; Anna Zicca; Carmen Barba; Renzo Guerrini; Lorenzo Genitori
Journal:  Epilepsia       Date:  2017-04       Impact factor: 5.864

10.  Effects of vagus nerve stimulation on cardiovascular regulation in patients with epilepsy.

Authors:  B Stemper; O Devinsky; T Haendl; G Welsch; M J Hilz
Journal:  Acta Neurol Scand       Date:  2007-11-13       Impact factor: 3.209

View more
  8 in total

1.  The autonomic signatures of epilepsy: diagnostic clues and novel treatment avenues.

Authors:  Roland D Thijs
Journal:  Clin Auton Res       Date:  2019-03-22       Impact factor: 4.435

2.  Effects of Intraoperative Vagal Nerve Stimulation on the Gastrointestinal Microbiome in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Megan M Haney; Aaron C Ericsson; Teresa E Lever
Journal:  Comp Med       Date:  2018-11-13       Impact factor: 0.982

3.  Dysautonomia following breast surgery: Disproportionate response to postoperative hematoma.

Authors:  Mary M Leech; Michael D Herrick; Kaela E Parnell; Kari M Rosenkranz
Journal:  Surg Open Sci       Date:  2022-05-25

Review 4.  Strategies for precision vagus neuromodulation.

Authors:  Umair Ahmed; Yao-Chuan Chang; Stefanos Zafeiropoulos; Zeinab Nassrallah; Larry Miller; Stavros Zanos
Journal:  Bioelectron Med       Date:  2022-05-30

5.  Quantification of clinically applicable stimulation parameters for precision near-organ neuromodulation of human splenic nerves.

Authors:  Isha Gupta; Antonino M Cassará; Ilya Tarotin; Matteo Donega; Jason A Miranda; David M Sokal; Sebastien Ouchouche; Wesley Dopson; Paul Matteucci; Esra Neufeld; Matthew A Schiefer; Alison Rowles; Paul McGill; Justin Perkins; Nikola Dolezalova; Kourosh Saeb-Parsy; Niels Kuster; Refet Firat Yazicioglu; Jason Witherington; Daniel J Chew
Journal:  Commun Biol       Date:  2020-10-16

6.  Validation and Reliability of a Novel Vagus Nerve Neurodynamic Test and Its Effects on Heart Rate in Healthy Subjects: Little Differences Between Sexes.

Authors:  Giacomo Carta; Agnese Seregni; Andrea Casamassima; Manuela Galli; Stefano Geuna; Pasquale Pagliaro; Matteo Zago
Journal:  Front Neurosci       Date:  2021-09-06       Impact factor: 4.677

7.  Reproducible asystole following vagal nerve stimulator lead replacement: a case report.

Authors:  Hayden Scott; Alexandra Moore; Hakan Paydak; Kelsey Hundley; Viktoras Palys
Journal:  BMC Neurol       Date:  2022-03-04       Impact factor: 2.474

8.  Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.

Authors:  Lucas Bonacossa Sant'Anna; Sérgio Lívio Menezes Couceiro; Eduardo Amar Ferreira; Mariana Bonacossa Sant'Anna; Pedro Rey Cardoso; Evandro Tinoco Mesquita; Guilherme Mendes Sant'Anna; Fernando Mendes Sant'Anna
Journal:  Front Cardiovasc Med       Date:  2021-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.